Related Experiment Video
Updated: Feb 24, 2026

09:20
Intradermal Inoculation of Mycobacterium avium in the Mouse Ear
Published on: July 3, 2025
1.4K
Nontuberculous Mycobacterium Infections Associated With Heater-Cooler Devices
Keith B Allen1, David D Yuh2, Suzanne B Schwartz3
1Department of Cardiothoracic Surgery, St. Luke's Mid America Heart Institute, Kansas City, Missouri.
The Annals of Thoracic Surgery
|August 20, 2017
Summary
Nontuberculous mycobacterium infections linked to heater-cooler devices (HCDs) after surgery can emerge years later and be fatal. Physician awareness is crucial for managing this public health risk.
Area of Science:
- Infectious Diseases
- Medical Device Safety
- Public Health
Background:
- Nontuberculous mycobacterium (NTM) infections have been linked to surgical procedures using extracorporeal circulation.
- Contaminated water from heater-cooler devices (HCDs) is suspected as the source of these infections.
Purpose of the Study:
- To evaluate the public health concern of NTM infections associated with HCDs.
- To educate physicians on identifying and managing these infections in at-risk patients.
Main Methods:
- A review of the Food and Drug Administration Medical Device Reporting (MDR) database from January 2010 to August 2016.
- Analysis of reports for patient infections and HCD contaminations, including infection type, patient data, and time to event.
Main Results:
- 339 MDR reports identified 107 patient infections (86 patients) and 232 device contaminations.
- Nontuberculous mycobacterium, particularly M. chimaera, was the most common organism.
- Infections were linked to cardiothoracic surgery, with a latency period up to 60 months post-procedure.
Conclusions:
- NTM infections from HCDs used in cardiothoracic surgery can have a long latency and be lethal.
- Increased awareness among cardiothoracic surgeons is vital for mitigating this public health threat.
Related Concept Videos
Pulmonary Tuberculosis I
1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pulmonary Tuberculosis III
1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
Pulmonary Tuberculosis II
1.7K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.7K
Pulmonary Tuberculosis IV
560
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
560
Pulmonary Tuberculosis V
669
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
669
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
6.0K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
6.0K

